Metabolic medicine · Phosphoglucomutase 1-congenital disorder of glycosylation

Symptoms & Warning Signs of PGM1-CDG

At a Glance

PGM1-CDG symptoms vary by age and may include poor growth, low muscle tone, exercise intolerance, seizures, and low blood sugar. Fainting, chest pain, severe muscle pain, dark urine, reduced urination, confusion, seizures, or unusual bleeding are emergency warning signs that need immediate medical evaluation.

As discussed in the orientation page, PGM1-CDG affects multiple systems because the missing enzyme plays a dual role in energy storage and protein building. Because of this, the symptoms you or your child experience may change over time, and a “mild” symptom today does not always predict the future course of the disease ^[1]^[2].

Symptoms by Life Stage

The way PGM1-CDG shows up depends heavily on age, though there is significant overlap between these stages.

Infancy and Early Childhood

In the earliest years, the disease often focuses on growth and the structure of the body.

Physical Features: Many infants are born with a cleft palate (a split in the roof of the mouth) or a bifid uvula (a split in the small tissue hanging at the back of the throat) ^[3]^[4].
Growth and Development: Children may experience poor growth or short stature (falling behind on height and weight charts) and hypotonia (low muscle tone, sometimes called “floppy baby syndrome”) ^[4]^[5].
Liver and Hormones: Doctors may find elevated transaminases (signs of liver stress) during routine blood work. There may also be endocrine issues, such as low levels of growth-related hormones ^[6]^[7].

Adolescence and Adulthood

As the body’s energy demands change, muscle-related symptoms often become more prominent.

Exercise Intolerance: You may experience extreme fatigue, muscle pain, or tightness very quickly after beginning physical activity ^[8]^[9].
Fluctuating Weakness: Some adults report muscle weakness that comes and goes, which can sometimes be mistaken for other neuromuscular disorders ^[10].

Neurological Symptoms

It was once thought that neurological issues in PGM1-CDG were only caused by low blood sugar. However, research now shows that significant neurological involvement—including seizures, intellectual disability, and delayed motor milestones—can occur even in patients who do not have severe hypoglycemia ^[11]^[1]. This makes early neurological check-ups essential. Note that developmental surveillance is standard, but you do not necessarily need a standing neurology visit if there are no clinical concerns.

Red Flags: When to Seek Emergency Care

Because PGM1-CDG involves the heart, energy metabolism, muscle tissue, and coagulation, certain symptoms require immediate medical evaluation at an Emergency Room.

1. Cardiac Red Flags (Heart Emergency)

The heart muscle can weaken (cardiomyopathy) or develop dangerous rhythms. Sudden cardiac death is a rare but reported complication of PGM1-CDG ^[12]^[13].

Seek help immediately for: Fainting (syncope), especially during exercise; heart palpitations or “fluttering” in the chest; sudden chest pain; or unexplained shortness of breath ^[12]^[14].

2. Metabolic Red Flags (Hypoglycemia)

Low blood sugar in PGM1-CDG is often ketotic, meaning the body is producing “ketones” because it cannot access its sugar stores. This can be made worse if the patient also has adrenal insufficiency (the body not making enough stress hormones) ^[4]^[1].

Seek help immediately for: Extreme sleepiness, lethargy, or difficulty waking up; seizures; cold, clammy skin; or sudden confusion and “fogginess” ^[11]^[1].

3. Muscle Red Flags (Acute Crisis)

Severe muscle breakdown, known as rhabdomyolysis, can occur after intense exercise or during a fever. This releases a protein called myoglobin into the blood, which can damage the kidneys ^[15]^[16].

Seek help immediately for: Dark, tea-colored, or cola-colored urine; severe, agonizing muscle pain or “locking” (contractures); or a sudden drop in how much urine you are producing ^[15]^[16].

4. Bleeding and Clotting Red Flags

About 67% of reported people with PGM1-CDG have abnormal coagulation (blood clotting) tests ^[17]. While regular coagulation testing informs procedural planning, it does not directly prevent a clot from forming.

Seek help immediately for: A new, swollen, painful, and warm limb (signs of a deep vein thrombosis); sudden breathlessness or chest pain; or uncontrolled/unusual bleeding ^[17]^[18].

Common questions in this guide

What symptoms can appear early in children with PGM1-CDG?

Early signs can include a cleft palate or bifid uvula, poor growth, short stature, and low muscle tone. Blood tests may show elevated liver enzymes, and some children have hormone-related problems. Symptoms vary, so one mild symptom does not predict the entire course.

Can PGM1-CDG cause neurological problems without low blood sugar?

A child or adult can have seizures, intellectual disability, or delayed motor milestones even without severe hypoglycemia, which means low blood sugar. Developmental monitoring is important, and new neurological concerns should be discussed with the clinical care team.

What heart symptoms require emergency care in PGM1-CDG?

Fainting, especially during exercise, a racing or fluttering heartbeat, sudden chest pain, or unexplained shortness of breath need immediate medical evaluation. These symptoms can signal heart muscle weakness or an abnormal heart rhythm.

When is muscle pain or dark urine an emergency?

Dark, tea-colored, or cola-colored urine, severe muscle pain or tightening, or a sudden decrease in urination can signal rhabdomyolysis, a serious breakdown of muscle. It can damage the kidneys, so seek emergency care, especially after intense exercise or a fever.

What are emergency signs of low blood sugar in PGM1-CDG?

Extreme sleepiness, difficulty waking, a seizure, cold clammy skin, or sudden confusion can be signs of dangerously low blood sugar. Emergency evaluation is especially important because hypoglycemia may be worsened by adrenal insufficiency.

Can PGM1-CDG cause bleeding or blood clots?

PGM1-CDG can be associated with abnormal blood-clotting tests, and symptoms may include unusual or uncontrolled bleeding. A new swollen, painful, warm limb, sudden breathlessness, or chest pain may signal a blood clot and requires urgent evaluation.

Get notified when new evidence is published on PGM1-CDG.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots.
Conte F, Morava E, Bakar NA, et al.
Molecular genetics and metabolism 2020; (131(1-2)):135-146 doi:10.1016/j.ymgme.2020.08.003.
PMID: 33342467
2
International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.
Altassan R, Radenkovic S, Edmondson AC, et al.
Journal of inherited metabolic disease 2021; (44(1)):148-163 doi:10.1002/jimd.12286.
PMID: 32681750
3
A novel phosphoglucomutase-deficient mouse model reveals aberrant glycosylation and early embryonic lethality.
Balakrishnan B, Verheijen J, Lupo A, et al.
Journal of inherited metabolic disease 2019; (42(5)):998-1007 doi:10.1002/jimd.12110.
PMID: 31077402
4
Phosphoglucomutase-1 deficiency: Intrafamilial clinical variability and common secondary adrenal insufficiency.
Loewenthal N, Haim A, Parvari R, Hershkovitz E
American journal of medical genetics. Part A 2015; (167A(12)):3139-43 doi:10.1002/ajmg.a.37294.
PMID: 26768186
5
Galactose treatment of a PGM1 patient presenting with restrictive cardiomyopathy.
Donoghue SE, White SM, Tan TY, et al.
JIMD reports 2021; (57(1)):29-37 doi:10.1002/jmd2.12177.
PMID: 33473337
6
PGM1 deficiency diagnosed during an endocrine work-up of low IGF-1 mediated growth failure.
Zeevaert R, Scalais E, Muino Mosquera L, et al.
Acta clinica Belgica 2016; (71(6)):435-437 doi:10.1080/17843286.2016.1142043.
PMID: 27351072
7
Pregnancy in a Woman with PGM1-CDG: Longitudinal Metabolic Follow-up During a Lactose-Supported Diet.
Akyüzlüer Güneş MS, Koç Yekedüz M, Sürücü Kara İ, et al.
Journal of clinical research in pediatric endocrinology 2026; doi:10.4274/jcrpe.galenos.2026.2026-7-12.
PMID: 42969211
8
News on Clinical Details and Treatment in PGM1-CDG.
Schrapers E, Tegtmeyer LC, Simic-Schleicher G, et al.
JIMD reports 2016; (26()):77-84 doi:10.1007/8904_2015_471.
PMID: 26303607
9
Congenital disorder of glycosylation type 1T with a novel truncated homozygous mutation in PGM1 gene and literature review.
Tian WT, Luan XH, Zhou HY, et al.
Neuromuscular disorders : NMD 2019; (29(4)):282-289 doi:10.1016/j.nmd.2019.01.001.
PMID: 30737079
10
[Electrophysiological evidence of impaired neuromuscular junction in a case of phosphoglucomutase 1 deficiency manifesting fluctuating muscle weakness].
Takenaka Y, Sekiguchi K, Sekiya H, et al.
Rinsho shinkeigaku = Clinical neurology 2020; (60(2)):152-156 doi:10.5692/clinicalneurol.cn-001375.
PMID: 31956197
11
Central nervous involvement is common in PGM1-CDG.
Radenkovic S, Witters P, Morava E
Molecular genetics and metabolism 2018; (125(3)):200-204 doi:10.1016/j.ymgme.2018.08.008.
PMID: 30262252
12
The congenital disorder of glycosylation in PGM1 (PGM1-CDG) can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.
Fernlund E, Andersson O, Ellegård R, et al.
Forensic science international. Genetics 2019; (43()):102111 doi:10.1016/j.fsigen.2019.06.012.
PMID: 31563034
13
Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency (PGM1-CDG).
Altassan R, Albert-Brotons DC, Alowain M, et al.
JIMD reports 2023; (64(2)):123-128 doi:10.1002/jmd2.12350.
PMID: 36873091
14
Limitations of galactose therapy in phosphoglucomutase 1 deficiency.
Nolting K, Park JH, Tegtmeyer LC, et al.
Molecular genetics and metabolism reports 2017; (13()):33-40 doi:10.1016/j.ymgmr.2017.07.010.
PMID: 28794993
15
Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series.
Radenkovic S, Johnsen C, Schulze A, et al.
Therapeutic advances in rare disease 2023; (4()):26330040221150269 doi:10.1177/26330040221150269.
PMID: 37181075
16
Phosphoglucomutase 1 deficiency misdiagnosed as Laron syndrome.
Uçaktürk SA, Özer E, Ceylan AC, Mengen E
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(2)):199-203 doi:10.1515/jpem-2025-0447.
PMID: 41099230
17
Coagulation abnormalities and vascular complications are common in PGM1-CDG.
Radenkovic S, Bleukx S, Engelhardt N, et al.
Molecular genetics and metabolism 2024; (142(4)):108530 doi:10.1016/j.ymgme.2024.108530.
PMID: 38968673
18
Oral D-galactose supplementation in PGM1-CDG.
Wong SY, Gadomski T, van Scherpenzeel M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(11)):1226-1235 doi:10.1038/gim.2017.41.
PMID: 28617415

This page is for informational purposes only and does not constitute medical advice. Contact your PGM1-CDG care team or emergency services for serious symptoms such as fainting, seizures, chest pain, dark urine, reduced urination, or unusual bleeding.